AstraZeneca COVID-19 vaccine
The NHS is continuing to administer the AstraZeneca Vaccination as medicines regulators have confirmed that it is safe and that the number of people who develop a blood clot is not higher than we would expect in the general population. Blood clots can occur for many different reasons and there has been nothing to suggest that the vaccine causes increased risk of clots.
About 17 million people in the European Union and the UK have received a dose of the Astra Zeneca vaccine, with less than 40 cases of blood clots reported as of last week. We would expect some people to develop a clot, regardless of having a vaccination and it is very likely this is the case for these 40 people.
The World Health Organization and Europe’s medicines regulator say there is no indication of a link between the vaccine and reports of blood clots.
The European Medicines Agency (EMA) – which is currently carrying out a review into the incidence of blood clots – said the vaccine could continue to be administered. It said the incidence of clotting in vaccinated people was “no higher than the number seen in the general population”. In addition, The UK medicines regulator has also confirmed that evidence “does not suggest” the jab causes clots, as it urged people in the country to get the vaccine when asked to do so.
These pauses for the AstraZeneca vaccine in some European countries are not because it is unsafe to give. It’s to allow time for experts to explore why a very small number of people who were recently given the shot also developed blood clots. When an illness occurs shortly after vaccination, it is right to question whether the shot might have contributed in any way. There is no indication or evidence, however, that the vaccine was linked or responsible and the figures are not higher than the number of blood clots you would expect to occur in the general population.
For more information please visit the link below: